Evidence map›Paper›PMID 36072899›Full record

ArticleDisease markers2022

Feiqun Yao, Qian Zhu

RetractedOpen access · hybridAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Disease markers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Retracted:Disease markers · 2023
    Article
4 · The record

Corrections and comments

  • Retraction · 2023-07-19Concerns/Issues about Data · Concerns/Issues about Results and/or Conclusions · Concerns/Issues about Referencing/Attributions · Concerns/Issues about Peer Review · Investigation by Journal/Publisher · Investigation by Third Party · Computer-Aided Content or Computer-Generated Content · Unreliable Results and/or Conclusions · · See also: https://pubpeer.com/publications/A4812CFC607F4C95E33866C424838E
  • Retracted
5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Feiqun YaoDepartment of Cardiology, Zhuji People's Hospital of Zhejiang Province, Zhuji, 311800 Zhejiang, China.
Qian ZhuDepartment of Pharmacy, Haining People's Hospital, Haining, 314400 Zhejiang, China.ORCID https://orcid.org/0000-0002-9095-8866
First People's Hospital of Nanning · CNZhuhai People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study is aimed at investigating the mechanism of Methods: Cardiomyocytes were exposed to OGD and then treated with Results: Conclusions:

Indexed as

GlucoseNF-kappa BApoptosis Regulatory ProteinsHumansInflammationMyocytes, CardiacNaphthalenesOxidative StressOxygenProto-Oncogene Proteins c-aktalpha-cyperoneApoptosis Regulatory ProteinsGlucoseNaphthalenesNF-kappa BOxygenProto-Oncogene Proteins c-akt

Identifiers

PMID36072899
PMCPMC9444414
OpenAlexW4293503866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.